Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02657447
Recruitment Status : Withdrawn (Study is no longer relevant)
First Posted : January 15, 2016
Last Update Posted : January 10, 2019
Sponsor:
Information provided by (Responsible Party):
Nordic Nanovector